← FDA DRUG APPROVALS

FDA ANDA · ANDA202660

DUTASTERIDE

Sponsor: AUROBINDO PHARMA LTD

APPLICATION
ANDA202660
TYPE
ANDA
ORIGINAL APPROVAL
2015-11-20
LATEST ACTION
2023-04-26
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

DUTASTERIDEPrescription
DUTASTERIDE 0.5MG · CAPSULE · ORAL

Approval history

2023-04-26Labeling · Supplement 3 · standardAP
2015-11-20UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →